Compelling Data in Breast Cancer Treatment with First-In-Class Cyclin A/B Inhibitor Presented at 2023 AACR-NCI-EORTC International Conference Epsilon09242023-10-23T08:17:12-07:00October 23, 2023|Press Releases|
